Ubicación: Global + English
Global Global Algérie Français Algeria English Angola Português Angola English Argentina Español Argentina English Australia English Austria Deutsch Austria English Azerbaijan English Azerbaijan Русский Bahrain English Bangladesh English Belgium English Belgium Français Belgium Nederlands Brazil Português Brazil English Bulgaria български Bulgaria English Cameroon English Cameroon Français Canada English Canada Français Chile Español Chile English China 中文 China 日本語 China English Colombia Español Colombia English Croatia English Czech Republic Čeština Czech Republic English Denmark English Djibouti English Ecuador Español Ecuador English Egypt English Estonia English Ethiopia English Finland Suomi Finland English France Français France English Georgia English Georgia Русский Germany Deutsch Germany English Ghana English Greece Ελληνικά Greece English Guatemala Español Guatemala English Hong Kong, China English Hong Kong, China 中文 Hungary Magyar Hungary English India English Indonesia English Iraq English Ireland English Italy Italiano Italy English Ivory Coast Français Ivory Coast English Japan 日本語 Japan English Jordan English Kazakhstan Русский Kazakhstan English Kenya English Kuwait English Kyrgyzstan Русский Kyrgyzstan English Latvia English Lithuania English Malaysia English Mauritius English Mauritius français (Maurice) Mexico Español Mexico English Moldova Română Moldova English Mongolia English Morocco English Morocco Français Mozambique Português Mozambique English Netherlands Nederlands Netherlands English New Zealand English Nigeria English Norway English Oman English Pakistan English Paraguay Español Paraguay English Peru Español Peru English Philippines English Poland Polski Poland English Portugal Português Portugal English Qatar English Republic of Korea 한국어 Republic of Korea English Romania Română Romania English Saudi Arabia English Serbia Српски Serbia English Singapore English Slovakia English Slovenia English South Africa English Spain English Spain Español Sri Lanka English Sweden English Switzerland Deutsch Switzerland Français Switzerland Italiano Switzerland English Tanzania English Thailand ไทย Thailand English Togo English Togo Français Tunisia English Tunisia Français Türkiye Türkçe Türkiye English Turkmenistan Русский Turkmenistan English Ukraine Українська Ukraine English United Arab Emirates English United Kingdom English Uruguay Español Uruguay English USA English Uzbekistan English Uzbekistan Русский Vietnam Tiếng Việt Vietnam English

Vapor Pressure Determination for Active Pharmaceutical Ingredients (APIs): Principles, Methods, and

Vapor pressure determination is a fundamental physicochemical characterization test for active pharmaceutical ingredients (APIs), delivering critical data for formulation development, stability evaluation, occupational health assessment, and regulatory submissions. Because most drug substances are low-volatility solids, accurate measurement requires specialized techniques such as static, dynamic, gas saturation, Knudsen effusion, and thermogravimetric methods. This article provides a comprehensive overview of API vapor pressure testing, covering principles, applicable standards, sample requirements, methodologies, and practical applications in the pharmaceutical industry.

Technical Overview

Vapor pressure is the pressure exerted by a vapor in thermodynamic equilibrium with its condensed phase (solid or liquid) at a given temperature. For active pharmaceutical ingredients, vapor pressure is a key physical parameter that quantifies volatility, influences sublimation behavior, residual solvent retention, packaging interactions, and potential exposure during manufacturing and handling. It is a required physicochemical endpoint in many regulatory data packages, including chemical registration dossiers and pharmaceutical development reports.

The temperature dependence of vapor pressure is governed by the Clausius–Clapeyron relationship, and experimental data are commonly regressed using the Antoine or Clausius–Clapeyron equations to derive enthalpy of vaporization (or sublimation) and to extrapolate values to ambient temperature. Most pharmaceutical solids exhibit very low volatility, typically in the range of 10-10 to 10-3 Pa at 20–25 °C, which places them far below the practical detection limit of direct manometric techniques. Consequently, measurements are often performed at elevated temperatures and the results are extrapolated to 20 °C or 25 °C, accompanied by a clear statement of the extrapolation uncertainty.

Internationally recognized frameworks for vapor pressure testing include OECD Test Guideline 104 (Vapour Pressure Curve), EU Method A.4 under REACH, US EPA Product Properties Test Guideline OPPTS 830.7950, and ASTM standards covering specific instrumental techniques. Pharmaceutical sponsors frequently delegate these studies to accredited third-party laboratories equipped with high-vacuum, microbalance, and thermal analysis instrumentation capable of validating measurements across more than eight orders of magnitude of pressure.

Testing Samples

Crystalline Solid APIs

Crystalline drug substances represent the majority of test articles. Polymorphic form, particle size, and residual solvent content can measurably affect sublimation behavior, so samples are characterized and documented prior to testing. Sufficient material is typically required to fill effusion cells or sample pans and to support repeat determinations.

Liquid and Low-Melting APIs

Liquid drug substances and oils with melting points below room temperature are amenable to static and dynamic methods, where a broader dynamic range of vapor pressure (up to approximately 105 Pa) can be measured directly without extrapolation.

Thermolabile and Highly Polar Compounds

APIs that decompose before generating measurable vapor pressure require methods operating at reduced temperature, such as the gas saturation technique or Knudsen effusion with high-sensitivity mass loss detection. Decomposition must be excluded by confirming constant mass-loss behavior and by post-test purity verification.

Salt Forms, Hydrates, and Amorphous Materials

Hydrates may lose water of crystallization before subliming, and amorphous materials may relax or crystallize during heating. These transformations must be identified by orthogonal techniques (for example, DSC and XRPD) so that the reported vapor pressure corresponds to the intended chemical species and physical form.

Testing Items

Standard deliverables for an API vapor pressure study typically include:

  • Vapor pressure at specified reference temperatures (commonly 20 °C and 25 °C), either measured directly or extrapolated from a temperature-dependent data set.
  • Full vapor pressure curve covering the experimentally accessible temperature range, presented in tabular and graphical (log P versus 1/T) form.
  • Regression parameters, including Antoine constants or Clausius–Clapeyron slope, with goodness-of-fit statistics.
  • Molar enthalpy of vaporization or sublimation derived from the regression.
  • Estimated boiling point or sublimation onset temperature where applicable.
  • Method validation data, covering repeatability, measurement uncertainty, and confirmation that no decomposition occurred during testing.

Testing Methods

Static Method (Isoteniscope) – ASTM D2879

The static method measures the equilibrium pressure of the vapor in a sealed, degassed system connected to a manometer. It is suitable for vapor pressures from roughly 10 Pa to 100 kPa and is well established for volatile liquids. Rigorous degassing is essential, because dissolved gases otherwise inflate the apparent pressure.

Dynamic Method – ASTM E1719

The dynamic method determines vapor pressure from boiling temperatures measured at controlled reduced pressures in an ebulliometer. It covers a wide range (approximately 10 Pa to 100 kPa) and delivers highly accurate data for liquids that can be boiled without decomposition.

Gas Saturation Method – OECD 104

An inert carrier gas is passed over or through the sample at a controlled flow rate until saturation. The transported mass of test substance is quantified analytically (for example, by trapping and HPLC or GC analysis), and vapor pressure is calculated from the carrier gas volume and evaporated mass. This method is the preferred OECD technique for low-volatility compounds down to approximately 10-6 Pa and is highly relevant to APIs.

Knudsen Effusion Method

The sample effuses through a calibrated orifice into high vacuum, and the mass loss is measured gravimetrically or with a quartz crystal microbalance. Vapor pressures as low as 10-8 to 10-10 Pa can be estimated at elevated temperatures. Because it is a comparative technique, reference compounds with well-characterized vapor pressures are tested in parallel to calibrate the effusion constant.

Thermogravimetric Analysis (TGA)

TGA-based approaches monitor the isothermal or scanning mass loss of a sample under controlled atmosphere and convert the evaporation or sublimation rate into vapor pressure using the Langmuir equation. The method requires only milligram quantities, is rapid, and is particularly useful for screening low-volatility pharmaceutical solids, although it provides comparative rather than absolute values unless calibrated with reference materials.

Differential Scanning Calorimetry – ASTM E1782

The DSC method determines vapor pressure from the thermal response of sealed or vented pans containing a small orifice, where the boiling endotherm is recorded at several controlled pressures. It is applicable to samples with vapor pressures above approximately 1 kPa and simultaneously yields enthalpy of vaporization.

Method Selection Strategy

  • Estimated vapor pressure above 1 kPa: static, dynamic, or DSC methods are appropriate.
  • Estimated vapor pressure between 10-2 and 103 Pa: static method with pressure transducers or effusion techniques.
  • Estimated vapor pressure below 10-2 Pa: gas saturation, Knudsen effusion, or TGA with extrapolation to ambient temperature.
  • Samples that decompose before measurable vaporization: gas saturation at reduced temperature, or reporting a limit value justified by mass-balance considerations.

Applications

Vapor pressure data for APIs support a broad spectrum of pharmaceutical development and compliance activities:

  • Regulatory submissions: physicochemical characterization sections of drug master files, investigational new drug applications, and marketing authorization dossiers.
  • Chemical registration: REACH and analogous global registration schemes that reference OECD 104 or EU Method A.4 data.
  • Occupational health and containment engineering: vapor pressure feeds into occupational exposure banding, containment strategy selection, and airborne concentration modeling for potent compounds.
  • Formulation and process development: assessment of sublimation loss during drying, milling, tableting, and film coating; selection of drying temperature and vacuum conditions; and evaluation of content uniformity risks for volatile actives.
  • Inhalation products: volatility characterization of drug substances and volatile excipients or propellants used in metered dose inhalers and nasal sprays.
  • Packaging and stability: prediction of migration, sorption, and dose loss through primary packaging over the proposed shelf life.
  • Environmental risk assessment: input parameter for fate modeling of volatile emissions from manufacturing sites.
  • Impurity control: understanding of volatility for volatile genotoxic impurities or residual solvents in support of control strategies.

FAQ

Why is vapor pressure important for APIs when most drug substances are not volatile?

Even extremely low volatility has practical consequences. Sublimation losses can affect assay and content uniformity during drying and handling; airborne drug substance determines containment and occupational exposure requirements; and regulators expect the parameter as part of a complete physicochemical profile. For low-volatility compounds, a reported limit value with scientific justification is often acceptable.

Which reference temperatures are typically reported?

Vapor pressure is conventionally reported at 20 °C and 25 °C. Because most APIs cannot be measured directly at these temperatures, measurements are performed over an elevated temperature range and extrapolated using the Clausius–Clapeyron or Antoine relationship, with extrapolation distance clearly documented.

How much sample is required for testing?

Requirements depend on the method. TGA and DSC methods need only a few milligrams per run. Knudsen effusion typically requires tens of milligrams per cell, and the gas saturation method may require several hundred milligrams to grams depending on the volatility and analytical sensitivity. Studies should always be planned with sufficient material for replicate measurements and reference compound calibration.

How are very low vapor pressures verified?

For compounds below 10-6 Pa, gas saturation and Knudsen effusion methods with validated analytical detection, combined with rigorous blank control and reference material calibration, are used. When extrapolation exceeds several orders of magnitude, results are generally reported as estimates or upper-limit values in accordance with OECD 104 guidance.

What quality criteria should a testing laboratory demonstrate?

A competent provider should hold ISO/IEC 17025 accreditation or equivalent quality certification for the specific technique, use calibrated reference substances traceable to established vapor pressure data, verify sample integrity before and after testing (for example, by HPLC assay or DSC), and report complete regression data with measurement uncertainty and extrapolation assumptions.

Can vapor pressure be measured for a salt or hydrate form of an API?

Yes, but the measurement must be designed to isolate the target process. Hydrates may dehydrate before subliming, and salts can decompose rather than sublime. Orthogonal thermal characterization is used to assign the measured transition correctly, and reporting should state explicitly which physical process the vapor pressure value represents.

Why Choose ZKGX?

  • State-of-the-art analytical equipment
  • Highly qualified scientific team
  • Fast turnaround time
  • Competitive pricing